Literature DB >> 18688057

Evidence-based recommendations for cancer fatigue, anorexia, depression, and dyspnea.

Sydney M Dy1, Karl A Lorenz, Arash Naeim, Homayoon Sanati, Anne Walling, Steven M Asch.   

Abstract

PURPOSE The experience of patients with cancer often involves symptoms of fatigue, anorexia, depression, and dyspnea. METHODS We developed a set of standards through an iterative process of structured literature review and development and refinement of topic areas and standards and subjected recommendations to rating by a multidisciplinary expert panel. Results For fatigue, providers should screen patients at the initial visit, for newly identified advanced cancer, and at chemotherapy visits; assess for depression and insomnia in newly identified fatigue; and follow up after treatment for fatigue or a secondary cause. For anorexia, providers should screen at the initial visit for cancer affecting the oropharynx or gastrointestinal tract or advanced cancer, evaluate for associated symptoms, treat underlying causes, provide nutritional counseling for patients undergoing treatment that may affect nutritional intake, and follow up patients given appetite stimulants. For depression, providers should screen newly diagnosed patients, those started on chemotherapy or radiotherapy, those with newly identified advanced disease, and those expressing a desire for hastened death; document a treatment plan in diagnosed patients; and follow up response after treatment. For general dyspnea, providers should evaluate for causes of new or worsening dyspnea, treat or symptomatically manage underlying causes, follow up to evaluate treatment effectiveness, and offer opioids in advanced cancer when other treatments are unsuccessful. For dyspnea and malignant pleural effusions, providers should offer thoracentesis, follow up after thoracentesis, and offer pleurodesis or a drainage procedure for patients with reaccumulation and dyspnea. CONCLUSION These standards provide a framework for evidence-based screening, assessment, treatment, and follow-up for cancer-associated symptoms.

Entities:  

Mesh:

Year:  2008        PMID: 18688057     DOI: 10.1200/JCO.2007.15.9525

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  40 in total

1.  A randomized, double-blind, placebo-controlled study of oral coenzyme Q10 to relieve self-reported treatment-related fatigue in newly diagnosed patients with breast cancer.

Authors:  Glenn J Lesser; Doug Case; Nancy Stark; Susan Williford; Jeff Giguere; L Astrid Garino; Michelle J Naughton; Mara Z Vitolins; Mark O Lively; Edward G Shaw
Journal:  J Support Oncol       Date:  2013-03

2.  Opportunities to Improve Detection and Treatment of Depression Among Patients With Breast Cancer Treated in an Integrated Delivery System.

Authors:  Devon K Check; Marilyn L Kwan; Neetu Chawla; Stacie B Dusetzina; Emily Valice; Isaac J Ergas; Janise M Roh; Tatjana Kolevska; Donald L Rosenstein; Lawrence H Kushi
Journal:  J Pain Symptom Manage       Date:  2018-12-01       Impact factor: 3.612

3.  TNF/TNFR1 signaling mediates doxorubicin-induced diaphragm weakness.

Authors:  Laura A A Gilliam; Jennifer S Moylan; Leonardo F Ferreira; Michael B Reid
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-11-19       Impact factor: 5.464

4.  Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery.

Authors:  Soon-Hyun Ahn; Hyun Jun Hong; Soon Young Kwon; Kee Hwan Kwon; Jong-Lyel Roh; Junsun Ryu; Jun Hee Park; Seung-Kuk Baek; Guk Haeng Lee; Sei Young Lee; Jin Choon Lee; Man Ki Chung; Young Hoon Joo; Yong Bae Ji; Jeong Hun Hah; Minsu Kwon; Young Min Park; Chang Myeon Song; Sung-Chan Shin; Chang Hwan Ryu; Doh Young Lee; Young Chan Lee; Jae Won Chang; Ha Min Jeong; Jae-Keun Cho; Wonjae Cha; Byung Joon Chun; Ik Joon Choi; Hyo Geun Choi; Kang Dae Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2017-01-03       Impact factor: 3.372

5.  Creating computable algorithms for symptom management in an outpatient thoracic oncology setting.

Authors:  Mary E Cooley; David F Lobach; Ellis Johns; Barbara Halpenny; Toni-Ann Saunders; Guilherme Del Fiol; Michael S Rabin; Pamela Calarese; Isidore L Berenbaum; Ken Zaner; Kathleen Finn; Donna L Berry; Janet L Abrahm
Journal:  J Pain Symptom Manage       Date:  2013-05-13       Impact factor: 3.612

6.  Postdoctoral Research Training in Palliative Care: Lessons Learned From a T32 Program.

Authors:  Erin K Kross; Abby R Rosenberg; Ruth A Engelberg; J Randall Curtis
Journal:  J Pain Symptom Manage       Date:  2019-11-24       Impact factor: 3.612

7.  Role of pain medications, consultants, and other services in improved pain control of elderly adults with cancer in geriatric evaluation and management units.

Authors:  Ryan Nipp; Richard Sloane; Arati V Rao; Kenneth E Schmader; Harvey J Cohen
Journal:  J Am Geriatr Soc       Date:  2012-10-04       Impact factor: 5.562

8.  Relationship between weakness and phase angle in advanced cancer patients with fatigue.

Authors:  A Navigante; P Cresta Morgado; O Casbarien; N López Delgado; R Giglio; M Perman
Journal:  Support Care Cancer       Date:  2013-01-16       Impact factor: 3.603

9.  Assessment of factors that contribute to decreased quality of life in Gynecologic Oncology Group ovarian cancer trials.

Authors:  Vivian E von Gruenigen; Helen Q Huang; Karen M Gil; Heidi E Gibbons; Bradley J Monk; Peter G Rose; Deborah K Armstrong; David Cella; Lari Wenzel
Journal:  Cancer       Date:  2009-10-15       Impact factor: 6.860

10.  Do high symptom scores trigger clinical actions? An audit after implementing electronic symptom screening.

Authors:  Hsien Seow; Jonathan Sussman; Lorraine Martelli-Reid; Greg Pond; Daryl Bainbridge
Journal:  J Oncol Pract       Date:  2012-08-21       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.